Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 44624-44625 [2017-20424]
Download as PDF
<![CDATA[
44624
Federal Register / Vol. 82, No. 184 / Monday, September 25, 2017 / Notices
4. Use of Funds
An applicant that receives an award
under this announcement is expected to
manage assistance agreement funds
efficiently and effectively, and make
sufficient progress towards completing
the project activities described in the
work-plan in a timely manner. The
assistance agreement will include terms
and conditions related to implementing
this requirement.
REGIONAL STATE AND TRIBAL BROWNFIELDS CONTACTS
Region
State
Tribal
1. CT, ME, MA,
NH, RI, VT.
James Byrne, 5 Post Office Square, Suite 100 (OSRR07–2),
Boston, MA 02109–3912, Phone (617) 918–1389 Fax (617)
918–1294.
John Struble, 290 Broadway, 18th Floor, New York, NY
10007–1866, Phone (212) 637–4291 Fax (212) 637–3083.
Michael Taurino, 1650 Arch Street (3HS51), Philadelphia, PA
19103, Phone (215) 814–3371 Fax (215) 814–3274.
Cindy Nolan, 61 Forsyth Street SW., 10th Fl (9T25), Atlanta,
GA 30303–8960, Phone (404) 562–8425 Fax (404) 562–
8788.
Jan Pels, 77 West Jackson Boulevard (SB–5J), Chicago, IL
60604–3507, Phone (312) 886–3009 Fax (312) 692–2161.
AmyJean McKeown, 5 Post Office Square, Suite 100
(OSRR07–2), Boston, MA 02109–3912, Phone (617) 918–
1248 Fax (617) 918–1294.
Phillip Clappin, 290 Broadway, 18th Floor, New York, NY
10007–1866, Phone (212) 637–4431 Fax (212) 637–3083.
2. NJ, NY, PR,
VI.
3. DE, DC, MD,
PA, VA, WV.
4. AL, FL, GA,
KY, MS, NC,
SC, TN.
5. IL, IN, MI,
MN, OH, WI.
6. AR, LA, NM,
OK, TX.
7. IA, KS, MO,
NE.
8. CO, MT, ND,
SD, UT, WY.
asabaliauskas on DSKBBXCHB2PROD with NOTICES
9. AZ, CA, HI,
NV, AS, GU,
MP.
10. AK, ID, OR,
WA.
Amber Howard, 1445 Ross Avenue, Suite 1200 (6SF), Dallas, TX 75202–2733, Phone (214) 665–3172 Fax (214)
665–6660.
Susan Klein, 11201 Renner Boulevard (SUPRSTAR),
Lenexa, KS 66219, Phone (913) 551–7786 Fax (913) 551–
9786.
Christina Wilson, 1595 Wynkoop Street (EPR–AR), Denver,
CO 80202–1129, Phone (303) 312–6706 Fax (303) 312–
6065.
Eugenia Chow, 75 Hawthorne St. (SFD–6–1), San Francisco,
CA 94105, Phone (415) 972–3160 Fax (415) 947–3520.
Olga Perry, 61 Forsyth Street SW., 10th Fl (9T25), Atlanta,
GA 30303–8960, Phone (404) 562–8534 Fax (404) 562–
8788.
Kirstin Kuenzi, 77 West Jackson Boulevard (SB–5J), Chicago, IL 60604–3507, Phone (312) 886–6015 Fax (312)
697–2075.
Freda Hardaway, 1445 Ross Avenue, Suite 1200 (6SF), Dallas, TX 75202–2733, Phone (214) 665–8342 Fax (214)
665–6660.
Jennifer Morris, 11201 Renner Boulevard (SUPRSTAR),
Lenexa, KS 66219, Phone (913) 551–7341 Fax (913) 551–
9341.
Melisa Devincenzi, 1595 Wynkoop Street (EPR–AR), Denver,
CO 80202–1129, Phone (303) 312–6377 Fax (303) 312–
6962.
Jose Garcia, Jr., 600 Wilshire Blvd, Suite 1460, Los Angeles,
CA 90017, Phone (213) 244–1811 Fax (213) 244–1850.
Mary K. Goolie, 222 West 7th Avenue #19 (AOO), Anchorage, AK 99513 Phone (907) 271–3414 Fax (907) 271–
3424.
Mary K. Goolie, 222 West 7th Avenue #19 (AOO), Anchorage, AK 99513 Phone (907) 271–3414 Fax (907) 271–
3424.
XI. Statutory and Executive Order
Reviews
Under Executive Order 12866 (58 FR
51735, October 4, 1993), this action is
not a ‘‘significant regulatory action’’ and
is therefore not subject to review under
Executive Orders 12866 and 13563 (76
FR 3821, January 21, 2011). Because this
action is not subject to notice and
comment requirements under the
Administrative Procedures Act or any
other statute, it is not subject to the
Regulatory Flexibility Act (5 U.S.C. 601
et seq.) or Sections 202 and 205 of the
Unfunded Mandates Reform Act of 1999
(UMRA) (Pub. L. 104–4). In addition,
this action does not significantly or
uniquely affect small governments. This
action does not create new binding legal
requirements that substantially and
directly affect Tribes under Executive
Order 13175 (63 FR 67249, November 9,
2000). This action does not have
significant Federalism implications
under Executive Order 13132 (64 FR
43255, August 10, 1999). Because this
action has been exempted from review
under Executive Order 12866, this
action is not subject to Executive Order
13211, entitled Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use (66
VerDate Sep<11>2014
19:45 Sep 22, 2017
Jkt 241001
FR 28355, May 22, 2001) or Executive
Order 13045, entitled Protection of
Children from Environmental Health
Risks and Safety Risks (62 FR 19885,
April 23, 1997). This action does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA), 44
U.S.C. 3501 et seq., nor does it require
any special considerations under
Executive Order 12898, entitled Federal
Actions to Address Environmental
Justice in Minority Populations and
Low-Income Populations (59 FR 7629,
February 16, 1994). This action does not
involve technical standards; thus, the
requirements of Section 12(d) of the
National Technology Transfer and
Advancement Act of 1995 (15 U.S.C.
272 note) do not apply. The
Congressional Review Act, 5 U.S.C. 801
et seq., generally provides that before
certain actions may take effect, the
agency promulgating the action must
submit a report, which includes a copy
of the action, to each House of the
Congress and to the Comptroller General
of the United States. Because this final
action does not contain legally binding
requirements, it is not subject to the
Congressional Review Act.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Dated: September 1, 2017.
David R. Lloyd,
Director, Office of Brownfields and Land
Revitalization, Office of Land and Emergency
Management.
[FR Doc. 2017–20436 Filed 9–22–17; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
E:\FR\FM\25SEN1.SGM
25SEN1
Federal Register / Vol. 82, No. 184 / Monday, September 25, 2017 / Notices
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than October 20,
2017.
A. Federal Reserve Bank of
Minneapolis (Brendan S. Murrin,
Assistant Vice President) 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. Full Service Insurance Agency, Inc.,
Buxton, North Dakota; to acquire 100
percent of the voting shares of First and
Farmers Bank Holding Company and
thereby indirectly acquire shares of The
First and Farmers Bank, both of
Portland, North Dakota.
Board of Governors of the Federal Reserve
System, September 20, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–20424 Filed 9–22–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–N–4952]
Food and Drug Administration Clinical
Trial Requirements, Regulations,
Compliance, and Good Clinical
Practice; Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public workshop.
The Food and Drug
Administration (FDA) is announcing an
educational conference co-sponsored
with the Society of Clinical Research
Associates (SOCRA). The public
workshop on FDA’s clinical trial
requirements is designed to aid the
clinical research professional’s
understanding of the mission and
authority of FDA and to facilitate
interaction with FDA representatives.
The program will focus on the
relationships among FDA and clinical
trial staff, investigators, and
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:45 Sep 22, 2017
Jkt 241001
institutional review boards (IRBs).
Individual FDA representatives will
discuss the informed consent process
and informed consent documents;
regulations relating to drugs, devices,
and biologics; and inspections of
clinical investigators, IRBs, and research
sponsors.
DATES: The public workshop will be
held on November 15 and 16, 2017,
from 8 a.m. to 5 p.m. See the
SUPPLEMENTARY INFORMATION section for
registration date and information.
ADDRESSES: The public workshop will
be held at the Wyndham Lake Buena
Vista Resort, 1850 Hotel Plaza Blvd.,
Lake Buena Vista, FL 32830, 407–828–
4444.
FOR FURTHER INFORMATION CONTACT: Kim
Prenter, Food and Drug Administration,
15100 NW. 67th Ave., Suite 400, Miami
Lakes, FL 33014, 305–816–1474, Fax:
305–816–1536; or Society of Clinical
Research Associates (SOCRA), 530 West
Butler Ave., Suite 109, Chalfont, PA
18914, 800–762–7292, Fax 215–822–
8633, email: SoCRAmail@aol.com, Web
site: https://www.socra.org.
SUPPLEMENTARY INFORMATION:
I. Background
The public workshop helps fulfill the
Department of Health and Human
Services’ and FDA’s important mission
to protect the public health. The public
workshop will provide those engaged in
FDA-regulated (human) clinical trials
with information on a number of topics
concerning FDA requirements related to
clinical investigations, informed
consent, and inspections of clinical
investigators and IRBs.
FDA has made education of the drug
and device manufacturing community a
high priority to help ensure the quality
of FDA-regulated drugs and devices.
The public workshop helps to achieve
objectives set forth in section 406 of the
Food and Drug Administration
Modernization Act of 1997 (21 U.S.C.
393), which includes working closely
with stakeholders and maximizing the
availability and clarity of information to
stakeholders and the public. The
workshop also is consistent with the
Small Business Regulatory Enforcement
Fairness Act of 1996 (Pub. L. 104–121),
as outreach activities by Government
agencies to small businesses.
II. Topics for Discussion
Topics for discussion include the
following: (1) What FDA Expects in a
Pharmaceutical Clinical Trial; (2)
Adverse Event Reporting—Science,
Regulation, Error and Safety; (3) Part 11
Compliance—Electronic Signatures; (4)
Informed Consent Regulations; (5) IRB
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
44625
Regulations and FDA Inspections; (6)
Keeping Informed and Working
Together; (7) FDA Conduct of Clinical
Investigator Inspections; (8) Meetings
with FDA: Why, When, and How; (9)
Investigator Initiated Research; (10)
Medical Device Aspects of Clinical
Research; (11) Working with FDA’s
Center for Biologics Evaluation and
Research; and (12) The Inspection Is
Over—What Happens Next? Possible
FDA Compliance Actions.
III. Participating in the Public
Workshop
Registration: Attendees are
responsible for their own
accommodations. Please mention
SOCRA to receive the hotel room rate of
$129 plus applicable taxes (available
until October 16, 2017, or until the
SOCRA room block is filled). For
additional registration and meeting
information, visit https://
www.socra.org/ or https://
www.socra.org/conferences-andeducation/live-conferences/fda-clinicaltrial-requirements-regulationscompliance-and-gcp-conference/
register/.
Registrations fees are as follows: $575
for SOCRA members, $650 for nonmembers (includes membership), $450
for Federal Government members, $525
for Federal Government non-members,
and fee waived for FDA Employees.
The registration fee covers expenses
including refreshments, lunch,
materials, and speaker expenses.
Registration for the conference is open
through November 14, 2017.
If you need special accommodations
due to a disability, please contact Kim
Prenter (see FOR FURTHER INFORMATION
CONTACT) at least 10 days in advance.
Other Issues for Consideration:
Extended periods of question and
answer and discussion have been
included in the program schedule. This
program offers 13.3 hours of Continuing
Medical Education (CME) and
Continuing Nursing Education (CNE)
credit. CME for Physicians: The Society
of Clinical Research Associates is
accredited by the Accreditation Council
for Continuing Medical Education to
provide continuing medical education
for physicians. CNE for Nurses: The
Society of Clinical Research Associates
is accredited as a provider of continuing
nursing education by the American
Nurses Credentialing Center’s
Commission on Accreditation. ANCC/
PSNA Provider Reference Number: 205–
3–A–09.
E:\FR\FM\25SEN1.SGM
25SEN1
]]>Agencies
[Federal Register Volume 82, Number 184 (Monday, September 25, 2017)]
[Notices]
[Pages 44624-44625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20424]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The applications will also be
[[Page 44625]]
available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing on the standards
enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also
involves the acquisition of a nonbanking company, the review also
includes whether the acquisition of the nonbanking company complies
with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless
otherwise noted, nonbanking activities will be conducted throughout the
United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than October 20, 2017.
A. Federal Reserve Bank of Minneapolis (Brendan S. Murrin,
Assistant Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota
55480-0291:
1. Full Service Insurance Agency, Inc., Buxton, North Dakota; to
acquire 100 percent of the voting shares of First and Farmers Bank
Holding Company and thereby indirectly acquire shares of The First and
Farmers Bank, both of Portland, North Dakota.
Board of Governors of the Federal Reserve System, September 20,
2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017-20424 Filed 9-22-17; 8:45 am]
BILLING CODE P
